跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LC-2
首页
药物
LC-2
LC-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
LIQUID CRYSTALLINE POLYMERS
US 2002155146 A1
申请人: MATHIOWITZ EDITH
优先权: 2000
US
4 件公开
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
US 2015315222 A1
申请人: UNIVERSAL DISPLAY CORP
优先权: 2014
US
4 件公开
LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PSMA-EXPRESSING CANCERS
US 2021393809 A1
申请人: UNIV HEIDELBERT
优先权: 2018
CN
US
WO
3 件公开
METAL IRIDIUM COMPLEX AND ELECTROLUMINESCENT DEVICE
US 2024336836 A1
申请人: GUANGDONG AGLAIA OPTOELECTRONIC MAT CO LTD
优先权: 2021
CN
US
WO
3 件公开
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER
EP 4640225 A1
申请人: NEC CORP
优先权: 2022
CN
EP
WO
3 件公开
Method for evaluating in vivo protein nutrition based on LC-MS-MS technique
US 11549949 B2
申请人: UNIV NANJING AGRICULTURAL
优先权: 2017
CN
US
2 件公开
Methods of producing full-length antibodies using E. coli
US 12351850 B2
申请人: SUTRO BIOPHARMA INC
优先权: 2020
CN
US
2 件公开
METAL IRIDIUM COMPLEX AND APPLICATION THEREOF
US 20250388612 A1
申请人: SICHUAN AG RAY NEW MAT CO LTD
优先权: 2021
CN
US
2 件公开
METAL IRIDIUM COMPLEX AND USE THEREOF
US 20250366361 A1
申请人: GUANGDONG AGLAIA OPTOELECTRONIC MAT CO LTD
优先权: 2022
CN
US
2 件公开
KK-LC-1-TARGETING BINDING PROTEIN AND DERIVATIVE THEREOF, KIT, AND USE
WO 2025129861 A1
申请人: NANJING DRUM TOWER HOSPITAL
优先权: 2023
CN
WO
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈